These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 16331345)

  • 1. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
    Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Fisher B; Xu L; Mamounas EP
    J Natl Cancer Inst; 2003 Oct; 95(19):1467-76. PubMed ID: 14519753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
    Dignam JJ
    J Natl Cancer Inst Monogr; 2001; (30):36-43. PubMed ID: 11773290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
    Dignam JJ; Redmond CK; Fisher B; Costantino JP; Edwards BK
    Cancer; 1997 Jul; 80(1):80-90. PubMed ID: 9210712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
    Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
    Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
    BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
    Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M
    Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
    Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW; Schneider BP
    Cancer; 2022 Jun; 128(11):2174-2181. PubMed ID: 35285940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
    McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
    Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study.
    Conroy SM; Maskarinec G; Wilkens LR; White KK; Henderson BE; Kolonel LN
    Breast Cancer Res Treat; 2011 Sep; 129(2):565-74. PubMed ID: 21499688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    Kerlikowske K; Gard CC; Tice JA; Ziv E; Cummings SR; Miglioretti DL;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.
    McCaskill-Stevens W; Wilson J; Bryant J; Mamounas E; Garvey L; James J; Cronin W; Wickerham DL
    J Natl Cancer Inst; 2004 Dec; 96(23):1762-9. PubMed ID: 15572758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.
    Kabat GC; Ginsberg M; Sparano JA; Rohan TE
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1181-1188. PubMed ID: 28004356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
    Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
    J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.